COMMUNIQUÉS West-GlobeNewswire

Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
12/02/2026
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
12/02/2026
ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
12/02/2026
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product Seeking to develop and commercialize new tethered continuous [...]
OKYO Pharma Announces Public Offering of Ordinary Shares
12/02/2026
LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
12/02/2026
VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company [...]
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
12/02/2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI ( [...]
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
12/02/2026
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31 [...]
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results
12/02/2026
MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results: Q4 2025 Q4 [...]
Northwestern Medicine and Founders Factory to scale European AI ventures into America’s leading health system
12/02/2026
AI is driving healthcare’s next wave: AI and deeptech advancements are transforming healthcare infrastructure, delivering novel approaches to safer, more efficient and more personalised patient care Advancing innovation [...]
FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
12/02/2026
White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to [...]
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
12/02/2026
Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult [...]
La Croix-Rouge canadienne recueille des dons pour venir en aide aux personnes éprouvées par la tragédie à Tumbler Ridge, en Colombie-Britannique
12/02/2026
OTTAWA, Ontario, 12 févr. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne s’emploie à soutenir les personnes touchées par la tragédie survenue à Tumbler Ridge, en Colombie-Britannique. L’organisation a mis sur pied [...]
GENFIT va recevoir un paiement d’étape de 20 M$ suite au dépassement du seuil des 200 M$ de ventes nettes d’Iqirvo® par Ipsen dès sa première année complète de commercialisation
12/02/2026
Ventes nettes d’Iqirvo® dans la PBC par Ipsen atteignant 88 M$ au 4T25, portant le total annuel pour 2025 à 208 M$, déclenchant le premier paiement d’étape 1 commercial pour GENFIT plus tôt que prévu Confirmation par [...]
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
12/02/2026
Ipsen reported US$88M of Iqirvo® net sales in PBC for 4Q25, bringing 2025 sales to US$208M, triggering the first commercial milestone payment to GENFIT ahead of schedule 1 Ipsen confirmed its commitment to launch a [...]
Canadian Red Cross launches appeal to support people impacted by the tragedy in Tumbler Ridge, B.C.
12/02/2026
OTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working to support those impacted by the tragedy in Tumbler Ridge, B.C., and has launched the Tumbler Ridge Tragedy Appeal. Money raised will [...]
Pennant Announces Fourth Quarter and Year-End 2025 Earnings Release and Call
12/02/2026
EAGLE, Idaho, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Invitation to Idorsia's FY 2025 Financial Reporting webcast and conference call
12/02/2026
Idorsia will publish its Full Year 2025 Financial Reporting on Thursday February 26, at 07:00 CET. An investor webcast and conference call will be held to discuss the results on the same day. Date: Thursday, February 26 [...]
Beacon Behavioral Partners Expands into South Carolina with Carolina Psychiatry
12/02/2026
New partner brings advanced depression treatments to Anderson, Greenville, Seneca, and Spartanburg BATON ROUGE, La., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a physician-driven organization [...]
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
12/02/2026
Press Release – No. 3 / 2026 Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results Copenhagen, Denmark, February 12, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR- [...]

Pages